Manulife InvestChoice

COVID-19 Vaccination Reward Program

Due to the overwhelming response, the registration quota is full. ​
Thank you for your support!

*Terms and Conditions

  1. The COVID-19 Vaccinated Reward Program for Manulife InvestChoice Customers (“the Program”) is taking place from 3 August 2021 to 31 October 2021, both dates inclusive (“Program Period”).
  2. Only Manulife InvestChoice Account holders are eligible to participate in the Program (“Eligible Clients”).
  3. Front-end fee refund as a cash reward: The front-end fee paid from Trade-based Account or calculated for Asset-based Account held by Eligible Clients within the Program Period, will be refunded up to the amount of HK$10,000, subject to the condition below.
    The condition is that, during the Program Period, the Eligible Client must (i) complete a lumpsum fund subscription of HK$100,000 (or equivalent in other currencies) or above as New Investments, and (ii) successfully register for the Program via, to declare he or she has received at least one dose of COVID-19 vaccination.
  4. Each of the first 300 Eligible Clients who meet the condition stated in point 3 (“Eligible Participant”) will receive an email from Manulife Investment Management (Hong Kong) Limited (“Manulife”) within one month following the end of the Program Period. The reward will be deposited into the HKD Cash Account of the Eligible Participant’s Manulife InvestChoice Account within two months after the end of the Program Period.
  5. The Program shall not be open to any staff or in-house agent of Manulife group.
  6. Each Eligible Participant holding a single name Manulife InvestChoice Account can receive only one cash reward. For a joint-name Manulife InvestChoice Account, only one cash reward will be deposited into the HKD Cash Account held by the same joint-holders. Subscription fees refunded under other reward programs will not be refunded again.
  7. Manulife reserves the right to amend these terms and conditions at any time without prior notice. In the event of any dispute, Manulife has the absolute right to determine all matters in relation to the Program, including but not limited to termination of the Program, the Program Period, schedule for the cash reward distribution, change or cancellation of the cash reward, and determination of the eligibility of claiming a cash reward. Eligible Participants shall be requested to show their COVID-19 vaccination record to Manulife for determining their eligibility of receiving the cash reward.
  8. None of the parties involved (including Manulife) shall have any liability or obligation for any damages, losses, claims, liabilities, deaths, medical conditions, costs or expenses incurred or suffered by the Eligible Participants or any other persons as a result of their COVID-19 vaccinations or participation in the Program.
  9. Potential Eligible Participants and all other persons are advised to consult their doctors and seek medical advice as to whether or not they can receive any of the COVID-19 vaccinations. They shall take sole responsibility for any such decisions.

Investment involves risk. Investors should not make investment decisions based on this material alone and should read the offering document for details, including the risk factors, charges and features of the product. This material has not been reviewed by the Securities and Futures Commission. Issued by Manulife Investment Management (Hong Kong) Limited.